US Broker Ratings

Vaxcyte, Inc. (PCVX) Stock Analysis: Unlocking a Potential 234.91% Upside in Biotechnology

Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its ambitious pipeline of vaccine candidates aimed at tackling bacterial infectious diseases...

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 51.8% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a rising star in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment. Headquartered in Cambridge, Massachusetts, this clinical-stage..

Humana Inc. (HUM) Stock Analysis: Exploring an 18% Potential Upside Amid Healthcare Sector Dynamics

For investors eyeing the healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling case with its diversified offerings and solid market position. As a major player in the healthcare plans..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential and Analyst Ratings

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry in the United States. With a market capitalization of..

Merit Medical Systems, Inc. (MMSI): Investor Outlook on Growth Potential and Analyst Consensus

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $4.95 billion, the company..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 32.68% Potential Upside Amidst Robust Revenue Growth

Investors looking for opportunities in the healthcare sector may want to turn their attention to Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading innovator in the medical instruments and supplies industry...

ICON plc (ICLR) Investor Outlook: Navigating Volatility with a 23.95% Potential Upside

Investors looking for opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing candidate. The company, headquartered in Dublin, Ireland, is a global leader in providing outsourced..

Masimo Corporation (MASI) Stock Analysis: Exploring a 33.57% Potential Upside for Investors

Masimo Corporation (MASI), a prominent player in the healthcare sector, continues to capture investor attention with its innovative contributions to the medical devices industry. Headquartered in Irvine, California, Masimo is..

Biogen Inc. (BIIB) Stock Analysis: Unpacking a 19% Upside Potential Amidst Healthcare Innovation

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to intrigue investors with its innovative approach to neurological and neurodegenerative disease treatments. With a market capitalization of $20.89..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Leader Faces Mixed Signals Amidst Market Volatility

Investors with a keen eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) intriguing, particularly given its longstanding reputation in the eye health industry. With a..

Bruker Corporation (BRKR) Stock Analysis: Evaluating a 40.87% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing the attention of investors with its promising potential upside. Headquartered in..

Madrigal Pharmaceuticals (MDGL): Growth Potential in Biotech with a 9.53% Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising pipeline in the healthcare industry. With a market..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Giant with 7.36% Upside Potential

ResMed Inc. (RMD) stands as a formidable entity within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $40 billion, ResMed’s influence spans..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 24% Potential Upside in the Biotech Arena

Royalty Pharma plc (NASDAQ: RPRX) is carving out a distinct niche in the healthcare sector as a prominent player in the biotechnology industry. Specializing in the acquisition of biopharmaceutical royalties..

RadNet, Inc. (RDNT): Investor Outlook on a Promising Healthcare Innovator with 3.72% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $5.88 billion, RadNet is a major player..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 100% Revenue Growth and a Promising 13.42% Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a formidable player in the biotechnology sector, focusing primarily on RNA-targeted medicines. With a market capitalization of $9.72 billion, Ionis stands at the forefront..

Alkermes plc (ALKS) Stock Analysis: Unlocking a 49.65% Potential Upside in Biopharmaceuticals

Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its impressive potential upside of nearly 50%, positioning itself as a compelling contender in the healthcare sector. This Ireland-based biopharmaceutical company..

Stevanato Group S.p.A. (STVN) Stock Analysis: Solid Buy Ratings Propel a Promising 6.87% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) has emerged as a noteworthy player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. Headquartered in Piombino Dese, Italy, Stevanato Group..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Analysts Predict a Staggering 73% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with a remarkable potential upside that has captured the attention of investors. With a market capitalization of $8.14..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Understanding the 33% Upside Potential in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology industry, is making waves in the healthcare sector with its innovative approach to drug development. Based in the United Kingdom..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds